| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.081 | 0.2 |